BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19554475)

  • 1. Conflict between values and technology: perceptions of preimplantation genetic diagnosis among women at increased risk for hereditary breast and ovarian cancer.
    Quinn GP; Vadaparampil ST; King LM; Miree CA; Friedman S
    Fam Cancer; 2009; 8(4):441-9. PubMed ID: 19554475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with preimplantation genetic diagnosis acceptance among women concerned about hereditary breast and ovarian cancer.
    Vadaparampil ST; Quinn GP; Knapp C; Malo TL; Friedman S
    Genet Med; 2009 Oct; 11(10):757-65. PubMed ID: 19710615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes of high-risk women toward preimplantation genetic diagnosis.
    Quinn G; Vadaparampil S; Wilson C; King L; Choi J; Miree C; Friedman S
    Fertil Steril; 2009 Jun; 91(6):2361-8. PubMed ID: 18440521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High risk men's perceptions of pre-implantation genetic diagnosis for hereditary breast and ovarian cancer.
    Quinn GP; Vadaparampil ST; Miree CA; Lee JH; Zhao X; Friedman S; Yi S; Mayer J
    Hum Reprod; 2010 Oct; 25(10):2543-50. PubMed ID: 20713415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
    Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
    Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer.
    Menon U; Harper J; Sharma A; Fraser L; Burnell M; ElMasry K; Rodeck C; Jacobs I
    Hum Reprod; 2007 Jun; 22(6):1573-7. PubMed ID: 17428877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk consumers' perceptions of preimplantation genetic diagnosis for hereditary cancers: a systematic review and meta-analysis.
    Quinn GP; Pal T; Murphy D; Vadaparampil ST; Kumar A
    Genet Med; 2012 Feb; 14(2):191-200. PubMed ID: 22261755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Much more than a gene: hereditary breast and ovarian cancer, reproductive choices and family life.
    Dekeuwer C; Bateman S
    Med Health Care Philos; 2013 May; 16(2):231-44. PubMed ID: 22048863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners.
    Gietel-Habets JJ; de Die-Smulders CE; Derks-Smeets IA; Tibben A; Tjan-Heijnen VC; van Golde R; Gomez-Garcia E; Kets CM; van Osch LA
    Hum Reprod; 2017 Mar; 32(3):588-597. PubMed ID: 28073972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's experiences of undergoing BRCA1 and BRCA2 testing: organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster.
    Nippert I; Schlegelberger B;
    Community Genet; 2003; 6(4):249-58. PubMed ID: 15331871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
    Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
    J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes.
    Rich TA; Liu M; Etzel CJ; Bannon SA; Mork ME; Ready K; Saraiya DS; Grubbs EG; Perrier ND; Lu KH; Arun BK; Woodard TL; Schover LR; Litton JK
    Fam Cancer; 2014 Jun; 13(2):291-9. PubMed ID: 24072553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric testing of the decisional conflict scale: genetic testing hereditary breast and ovarian cancer.
    Katapodi MC; Munro ML; Pierce PF; Williams RA
    Nurs Res; 2011; 60(6):368-77. PubMed ID: 22048556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization.
    Levy DE; Garber JE; Shields AE
    J Gen Intern Med; 2009 Jul; 24(7):822-8. PubMed ID: 19455369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.
    Bakos AD; Hutson SP; Loud JT; Peters JA; Giusti RM; Greene MH
    Health Expect; 2008 Sep; 11(3):220-31. PubMed ID: 18816319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
    Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
    Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Having a child and PND/PGD access in women with a BRCA1/2 mutation? Different approach whether ill or healthy].
    Pellegrini I; Prodromou N; Coupier I; Huiart L; Moretta J; Noguès C; Julian-Reynier C
    Bull Cancer; 2014 Nov; 101(11):1001-8. PubMed ID: 25418592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation.
    Claes E; Evers-Kiebooms G; Boogaerts A; Decruyenaere M; Denayer L; Legius E
    Genet Test; 2004; 8(1):13-21. PubMed ID: 15140370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximising survival: the main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1/2.
    Jeffers L; Morrison PJ; McCaughan E; Fitzsimons D
    Eur J Oncol Nurs; 2014 Aug; 18(4):411-8. PubMed ID: 24731853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.